MarginsXMarginsX
Home › Markets › Health Care › KTWO

K2 Capital Acquisition Corporation Class A Ordinary Share (KTWO)

KTWO trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$10.13
+0.05% on the day
Market cap
$203.0M
Micro cap
Revenue
No annual revenue in SEC XBRL data for this filer
Net income
No annual revenue in SEC XBRL data for this filer

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerKTWO on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryCayman Islands
IPO year2026
SEC CIK0002086524
SEC industry codeBlank Checks
Incorporated inCayman Islands

Financials

No annual revenue in SEC XBRL data for this filer.

Warning signs

Cash runway
8.8 months
$823K cash at June 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Accordingly, while management believes that the Sponsor's commitment to provide Working Capital Loans will enable the Company to meet its working capital needs through the assessment period, the uncertainty regarding the Company's ability to consummate an initial Business Combination before the mandatory liquidation date raises substantial doubt about the Company's ability to continue as a going concern for a period "
10-Q 2026-11-13
Cash and burn$823K cash; operating cash flow -$281K a quarter.Report 2026-06-30
Shares outstanding20,041,161 (2026-11-13).Cover page 2026-11-13
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWithumSmith+Brown, PC, New York, New York, United StatesPCAOB Form AP 2026-03-27
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed$985K-$167K$823KNo debt tagsNeeds four quarters10-Q 2026-08-13
Q2 2026
2026-03-31
Not filed$301K-$395K$990KNo debt tagsNeeds four quarters10-Q 2026-08-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B42026-01-30
Latest annual report
ANNUAL REPORT
10-K2026-03-26
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-11-13
Latest current report
CURRENT REPORT
8-K2026-08-27

Source: SEC EDGAR submissions feed, 53 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.3%
1 month+0.4%
3 months+2.0%
Year to dateNot enough price history
1 yearNot enough price history
From 52-week high0.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
KTWORK2 Capital Acquisition Corporation Rights$0.1001
KTWOUK2 Capital Acquisition Corporation Units$10.29

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
UTMDUtah Medical Products Inc.$72.36+0.54%$206.2M
PDEXPro-Dex Inc.$64.48-1.80%$206.3M
ANIKAnika Therapeutics Inc.$12.92-3.58%$173.1M
OSUROraSure Technologies Inc.$3.60-0.55%$248.6M
KRMDKORU Medical Systems Inc. Common Stock (DE)$3.69-0.27%$160.1M
CLPTClearPoint Neuro Inc.$8.30-2.12%$266.1M
PROFProfound Medical Corp.$7.34-1.08%$268.8M
SSIISS Innovations International Inc.$1.35-18.67%$270.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier